Skip to main content
. 2018 May 8;2018:8253094. doi: 10.1155/2018/8253094

Table 4.

Details of adverse outcome.

Site of metastases PTC-GD Euthyroid
Bone 2 (6.8%) 1 (0.4%)
Lung 0 2 (0.8%)
Bone + lung 2 (6.8%) 4 (1.6%)
Local recurrence + lung 0 3 (1.3%)
Local recurrence + lung + bone 0 3 (1.3%)
Local recurrence 1 (3.4%) 4 (1.7%)